Vacuolating megalencephalic leukoencephalopathy with subcortical cysts: functional studies of novel variants in MLC1

Giorgia Montagna1, Oscar Teijido, Eleonore Eymard-Pierre

  • 1Molecular Medicine, IRCCS-Bambino Gesù Children's Hospital, Rome, Italy.

Human Mutation
|February 14, 2006
PubMed

Insights

Researchers identified nine new patients with vacuolating myelinopathy and analyzed the MLC1 gene for mutations. Nine novel mutations were found, but no correlation between mutation type and clinical features was observed.

Area of Science:

  • Genetics
  • Neurology
  • Molecular Biology

Background:

  • Vacuolating myelinopathy with subcortical cysts is a rare neurological disorder.
  • The MLC1 gene is implicated in myelin disorders.

Purpose of the Study:

  • To identify mutations in the MLC1 gene in patients with vacuolating myelinopathy.
  • To functionally characterize novel MLC1 variants.

Main Methods:

  • Genetic analysis of the MLC1 gene in nine patients.
  • Functional assays using a heterologous system to assess protein expression.

Main Results:

  • Twelve MLC1 mutations were detected in nine patients, with nine being novel.
  • Three novel missense variants and one leucine insertion were functionally assayed.
  • No correlation was found between MLC1 mutations, clinical presentation, and protein expression at the plasma membrane.

Conclusions:

  • Genetic variations in the MLC1 gene are associated with vacuolating myelinopathy.
  • Functional analysis of novel variants did not reveal a direct link to clinical severity or protein localization.
  • Further research is needed to understand the pathogenesis of this disorder.